Latest placebo Stories
A new research study from Brigham and Women's Hospital (BWH) that compares low-dose oral estrogen and low-dose non-hormonal venlafaxine hydrochloride extended release (XR) to placebo were both found effective in reducing the number of hot flashes and night sweats reported by menopausal women.
New York Times Best Seller 'You Are the Placebo' is an insightful book that shows how much power our mind has, and how meditation can help us to overcome various difficulties in life.
LONDON, May 19, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE: GSK) today presented data at the American Thoracic Society (ATS) from a late-stage clinical study.
- Investor Conference Call and Webcast Today at 8 p.m. EDT (5 p.m. PDT) - BRISBANE, Calif., May 18, 2014 /PRNewswire/ -- InterMune, Inc.
- Data Demonstrate Positive Trends in Lung Function and Pulmonary Exacerbations - SOUTH PLAINFIELD, N.J., May 16, 2014 /PRNewswire/ -- PTC Therapeutics, Inc.
TORONTO, May 15, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced the dosing of the first patient in a Phase 2
FREDERICK, Md., May 14, 2014 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today announced more detail on the interim results
WUPPERTAL, Germany and WHITEHOUSE STATION, New Jersey, May 8, 2014 /PRNewswire/ -- AiCuris and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today
"It’s simply magnificent.
A follow-up study of patients with Parkinson's disease (PD) who participated in an earlier "proof of concept" clinical trial using exenatide showed that improvements persisted twelve months after discontinuing exenatide therapy.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.